![Zofran](https://attorneyatlawmagazine.com/wp-content/uploads/2018/10/Zofran-300x156.png)
Morning Sickness Drug Zofran Linked to Birth Defects
Zofran was approved by the FDA in 1981 for treatment of nausea in cancer patients undergoing chemotherapy and post-operative patients. To this day, Zofran has never received FDA approval for use in pregnant women to treat nausea and vomiting of pregnancy (NVP). In 2012, The Center for BirThDefects Research and Prevention published a study that showed women who used Zofran